Brief: Bone Therapeutics To Highlight Osteogenic Properties Of Proprietary Allogenic
March 18 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* TO PRESENT DATA AT HERBERT FLEISCH / IFMRS WORKSHOP
* WILL HIGHLIGHT IN VITRO CHONDRO-OSTEOGENIC CHARACTERISTICS
* WILL HIGHLIGHT IN VIVO OSTEOGENIC PROPERTIES OF ITS
PROPRIETARY
ALLOGENIC EX VIVO DIFFERENTIATED BONE-FORMING CELLS DERIVED FROM
HUMAN BONE MARROW MESENCHYMAL STEM CELLS
Source text for Eikon: ID:nGNE9VcFn3
Further company coverage: BOTHE.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd